On the protective mechanisms of nitric oxide in acute pancreatitis

Background—Ectopic protease activation, microcirculatory changes, and leucocyte activation are the main events in the pathogenesis of acute pancreatitis. Nitric oxide (NO) is known to be a key mediator in the normal and inflamed pancreas. Aims—To investigate the targets on which NO exerts its effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 1998-09, Vol.43 (3), p.401-407
Hauptverfasser: Werner, J, Castillo, C Fernández-del, Rivera, J A, Kollias, N, Lewandrowski, K B, Rattner, D W, Warshaw, A L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 407
container_issue 3
container_start_page 401
container_title Gut
container_volume 43
creator Werner, J
Castillo, C Fernández-del
Rivera, J A
Kollias, N
Lewandrowski, K B
Rattner, D W
Warshaw, A L
description Background—Ectopic protease activation, microcirculatory changes, and leucocyte activation are the main events in the pathogenesis of acute pancreatitis. Nitric oxide (NO) is known to be a key mediator in the normal and inflamed pancreas. Aims—To investigate the targets on which NO exerts its effect in caerulein induced pancreatitis. Methods—Acute pancreatitis was induced in rats which additionally received either the NO synthase substrate, l-arginine; the NO donor, sodium nitroprusside; or the NO synthase inhibitor, N-nitro-l-arginine methyl ester (l-NAME). At six hours, pancreatic injury (oedema, leucocyte content, ectopic trypsinogen activation) was analysed and pancreatic oxygenation and perfusion were determined. A direct influence of NO on amylase secretion and trypsinogen activation was evaluated separately in vitro. Results—Both NO donors reduced the grade of inflammation. l-NAME increased the severity of inflammation, while decreasing pancreatic tissue oxygenation. Although neither amylase secretion nor intracellular trypsinogen activation in caerulein stimulated pancreatic acini was influenced by either NO donors or inhibitors, both NO donors decreased intrapancreatic trypsinogen activation peptide (TAP) and pancreatic oedema in vivo, andl-NAME increased TAP. Conclusions—NO protects against injury caused by pancreatitis in the intact animal but has no discernible effect on isolated acini. It is likely that in pancreatitis NO acts indirectly via microcirculatory changes, including inhibition of leucocyte activation and preservation of capillary perfusion.
doi_str_mv 10.1136/gut.43.3.401
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1727253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4017425991</sourcerecordid><originalsourceid>FETCH-LOGICAL-b572t-4bc2d5901d9e527fef39698f2f0259e672815b07dffe4876141f5357795005e83</originalsourceid><addsrcrecordid>eNp90c1rFDEYBvAgSl2rN6_CgKIXZ833x6VgF3WFYqWoeAuZTNLNOpNZk0yp_70puyzqwdMcnh8PT-YF4CmCS4QIf3M9lyUlS7KkEN0DC0S5bAmW8j5YQIhEywRVD8GjnLcQQikVOgEnSnJCpViA88vYlI1rdmkqzpZw45rR2Y2JIY-5mXwTQ0nBNtNt6F0TYmPsXCo30SZnSighPwYPvBmye3L4noKv7999Wa3bi8sPH1dvL9qOCVxa2lncMwVRrxzDwjtPFFfSYw8xU44LLBHroOi9d3UaRxR5RpgQikHInCSn4Gzfu5u70fXWxZLMoHcpjCb90pMJ-u8kho2-nm40ElhgRmrBy0NBmn7OLhc9hmzdMJjopjlrrhCkGN7B5__A7TSnWB9Xu4RSHEFOq3q9VzZNOSfnj1MQ1HeX0fUymhJNdL1M5c_-nH_Eh1PU_MUhN9mawaf6i0M-Mkw4hZBX1u5ZyMXdHmOTfmguiGD607eVvrqS6--f-bleV_9q77tx-_-BvwE9g7F_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779961064</pqid></control><display><type>article</type><title>On the protective mechanisms of nitric oxide in acute pancreatitis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Werner, J ; Castillo, C Fernández-del ; Rivera, J A ; Kollias, N ; Lewandrowski, K B ; Rattner, D W ; Warshaw, A L</creator><creatorcontrib>Werner, J ; Castillo, C Fernández-del ; Rivera, J A ; Kollias, N ; Lewandrowski, K B ; Rattner, D W ; Warshaw, A L</creatorcontrib><description>Background—Ectopic protease activation, microcirculatory changes, and leucocyte activation are the main events in the pathogenesis of acute pancreatitis. Nitric oxide (NO) is known to be a key mediator in the normal and inflamed pancreas. Aims—To investigate the targets on which NO exerts its effect in caerulein induced pancreatitis. Methods—Acute pancreatitis was induced in rats which additionally received either the NO synthase substrate, l-arginine; the NO donor, sodium nitroprusside; or the NO synthase inhibitor, N-nitro-l-arginine methyl ester (l-NAME). At six hours, pancreatic injury (oedema, leucocyte content, ectopic trypsinogen activation) was analysed and pancreatic oxygenation and perfusion were determined. A direct influence of NO on amylase secretion and trypsinogen activation was evaluated separately in vitro. Results—Both NO donors reduced the grade of inflammation. l-NAME increased the severity of inflammation, while decreasing pancreatic tissue oxygenation. Although neither amylase secretion nor intracellular trypsinogen activation in caerulein stimulated pancreatic acini was influenced by either NO donors or inhibitors, both NO donors decreased intrapancreatic trypsinogen activation peptide (TAP) and pancreatic oedema in vivo, andl-NAME increased TAP. Conclusions—NO protects against injury caused by pancreatitis in the intact animal but has no discernible effect on isolated acini. It is likely that in pancreatitis NO acts indirectly via microcirculatory changes, including inhibition of leucocyte activation and preservation of capillary perfusion.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.43.3.401</identifier><identifier>PMID: 9863487</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Acute Disease ; acute pancreatitis ; Animals ; Arginine - therapeutic use ; Biological and medical sciences ; Blood ; Cells, Cultured ; Ceruletide ; Endothelium ; Enzyme Inhibitors - pharmacology ; Experiments ; Gastroenterology. Liver. Pancreas. Abdomen ; Laboratory animals ; leucocytes ; Leukocytes ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; microcirculation ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric oxide ; Nitric Oxide - physiology ; Nitric Oxide Donors - therapeutic use ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Nitroprusside - therapeutic use ; Oligopeptides - metabolism ; Other diseases. Semiology ; Pancreas ; Pancreas - drug effects ; Pancreas - metabolism ; Pancreas - pathology ; pancreatic secretion ; Pancreatitis - metabolism ; Pancreatitis - pathology ; Pancreatitis - prevention &amp; control ; Pathogenesis ; Rats ; Rats, Sprague-Dawley ; Rats, Wistar ; Rodents ; Spectrum analysis ; Vasodilator Agents - therapeutic use</subject><ispartof>Gut, 1998-09, Vol.43 (3), p.401-407</ispartof><rights>British Society of Gastroenterology</rights><rights>1998 INIST-CNRS</rights><rights>Copyright: 1998 British Society of Gastroenterology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b572t-4bc2d5901d9e527fef39698f2f0259e672815b07dffe4876141f5357795005e83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1727253/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1727253/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2364006$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9863487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Werner, J</creatorcontrib><creatorcontrib>Castillo, C Fernández-del</creatorcontrib><creatorcontrib>Rivera, J A</creatorcontrib><creatorcontrib>Kollias, N</creatorcontrib><creatorcontrib>Lewandrowski, K B</creatorcontrib><creatorcontrib>Rattner, D W</creatorcontrib><creatorcontrib>Warshaw, A L</creatorcontrib><title>On the protective mechanisms of nitric oxide in acute pancreatitis</title><title>Gut</title><addtitle>Gut</addtitle><description>Background—Ectopic protease activation, microcirculatory changes, and leucocyte activation are the main events in the pathogenesis of acute pancreatitis. Nitric oxide (NO) is known to be a key mediator in the normal and inflamed pancreas. Aims—To investigate the targets on which NO exerts its effect in caerulein induced pancreatitis. Methods—Acute pancreatitis was induced in rats which additionally received either the NO synthase substrate, l-arginine; the NO donor, sodium nitroprusside; or the NO synthase inhibitor, N-nitro-l-arginine methyl ester (l-NAME). At six hours, pancreatic injury (oedema, leucocyte content, ectopic trypsinogen activation) was analysed and pancreatic oxygenation and perfusion were determined. A direct influence of NO on amylase secretion and trypsinogen activation was evaluated separately in vitro. Results—Both NO donors reduced the grade of inflammation. l-NAME increased the severity of inflammation, while decreasing pancreatic tissue oxygenation. Although neither amylase secretion nor intracellular trypsinogen activation in caerulein stimulated pancreatic acini was influenced by either NO donors or inhibitors, both NO donors decreased intrapancreatic trypsinogen activation peptide (TAP) and pancreatic oedema in vivo, andl-NAME increased TAP. Conclusions—NO protects against injury caused by pancreatitis in the intact animal but has no discernible effect on isolated acini. It is likely that in pancreatitis NO acts indirectly via microcirculatory changes, including inhibition of leucocyte activation and preservation of capillary perfusion.</description><subject>Acute Disease</subject><subject>acute pancreatitis</subject><subject>Animals</subject><subject>Arginine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Cells, Cultured</subject><subject>Ceruletide</subject><subject>Endothelium</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Experiments</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Laboratory animals</subject><subject>leucocytes</subject><subject>Leukocytes</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>microcirculation</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Donors - therapeutic use</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Nitroprusside - therapeutic use</subject><subject>Oligopeptides - metabolism</subject><subject>Other diseases. Semiology</subject><subject>Pancreas</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - metabolism</subject><subject>Pancreas - pathology</subject><subject>pancreatic secretion</subject><subject>Pancreatitis - metabolism</subject><subject>Pancreatitis - pathology</subject><subject>Pancreatitis - prevention &amp; control</subject><subject>Pathogenesis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rats, Wistar</subject><subject>Rodents</subject><subject>Spectrum analysis</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp90c1rFDEYBvAgSl2rN6_CgKIXZ833x6VgF3WFYqWoeAuZTNLNOpNZk0yp_70puyzqwdMcnh8PT-YF4CmCS4QIf3M9lyUlS7KkEN0DC0S5bAmW8j5YQIhEywRVD8GjnLcQQikVOgEnSnJCpViA88vYlI1rdmkqzpZw45rR2Y2JIY-5mXwTQ0nBNtNt6F0TYmPsXCo30SZnSighPwYPvBmye3L4noKv7999Wa3bi8sPH1dvL9qOCVxa2lncMwVRrxzDwjtPFFfSYw8xU44LLBHroOi9d3UaRxR5RpgQikHInCSn4Gzfu5u70fXWxZLMoHcpjCb90pMJ-u8kho2-nm40ElhgRmrBy0NBmn7OLhc9hmzdMJjopjlrrhCkGN7B5__A7TSnWB9Xu4RSHEFOq3q9VzZNOSfnj1MQ1HeX0fUymhJNdL1M5c_-nH_Eh1PU_MUhN9mawaf6i0M-Mkw4hZBX1u5ZyMXdHmOTfmguiGD607eVvrqS6--f-bleV_9q77tx-_-BvwE9g7F_</recordid><startdate>19980901</startdate><enddate>19980901</enddate><creator>Werner, J</creator><creator>Castillo, C Fernández-del</creator><creator>Rivera, J A</creator><creator>Kollias, N</creator><creator>Lewandrowski, K B</creator><creator>Rattner, D W</creator><creator>Warshaw, A L</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19980901</creationdate><title>On the protective mechanisms of nitric oxide in acute pancreatitis</title><author>Werner, J ; Castillo, C Fernández-del ; Rivera, J A ; Kollias, N ; Lewandrowski, K B ; Rattner, D W ; Warshaw, A L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b572t-4bc2d5901d9e527fef39698f2f0259e672815b07dffe4876141f5357795005e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acute Disease</topic><topic>acute pancreatitis</topic><topic>Animals</topic><topic>Arginine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Cells, Cultured</topic><topic>Ceruletide</topic><topic>Endothelium</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Experiments</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Laboratory animals</topic><topic>leucocytes</topic><topic>Leukocytes</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>microcirculation</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Donors - therapeutic use</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Nitroprusside - therapeutic use</topic><topic>Oligopeptides - metabolism</topic><topic>Other diseases. Semiology</topic><topic>Pancreas</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - metabolism</topic><topic>Pancreas - pathology</topic><topic>pancreatic secretion</topic><topic>Pancreatitis - metabolism</topic><topic>Pancreatitis - pathology</topic><topic>Pancreatitis - prevention &amp; control</topic><topic>Pathogenesis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rats, Wistar</topic><topic>Rodents</topic><topic>Spectrum analysis</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Werner, J</creatorcontrib><creatorcontrib>Castillo, C Fernández-del</creatorcontrib><creatorcontrib>Rivera, J A</creatorcontrib><creatorcontrib>Kollias, N</creatorcontrib><creatorcontrib>Lewandrowski, K B</creatorcontrib><creatorcontrib>Rattner, D W</creatorcontrib><creatorcontrib>Warshaw, A L</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Werner, J</au><au>Castillo, C Fernández-del</au><au>Rivera, J A</au><au>Kollias, N</au><au>Lewandrowski, K B</au><au>Rattner, D W</au><au>Warshaw, A L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>On the protective mechanisms of nitric oxide in acute pancreatitis</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1998-09-01</date><risdate>1998</risdate><volume>43</volume><issue>3</issue><spage>401</spage><epage>407</epage><pages>401-407</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract>Background—Ectopic protease activation, microcirculatory changes, and leucocyte activation are the main events in the pathogenesis of acute pancreatitis. Nitric oxide (NO) is known to be a key mediator in the normal and inflamed pancreas. Aims—To investigate the targets on which NO exerts its effect in caerulein induced pancreatitis. Methods—Acute pancreatitis was induced in rats which additionally received either the NO synthase substrate, l-arginine; the NO donor, sodium nitroprusside; or the NO synthase inhibitor, N-nitro-l-arginine methyl ester (l-NAME). At six hours, pancreatic injury (oedema, leucocyte content, ectopic trypsinogen activation) was analysed and pancreatic oxygenation and perfusion were determined. A direct influence of NO on amylase secretion and trypsinogen activation was evaluated separately in vitro. Results—Both NO donors reduced the grade of inflammation. l-NAME increased the severity of inflammation, while decreasing pancreatic tissue oxygenation. Although neither amylase secretion nor intracellular trypsinogen activation in caerulein stimulated pancreatic acini was influenced by either NO donors or inhibitors, both NO donors decreased intrapancreatic trypsinogen activation peptide (TAP) and pancreatic oedema in vivo, andl-NAME increased TAP. Conclusions—NO protects against injury caused by pancreatitis in the intact animal but has no discernible effect on isolated acini. It is likely that in pancreatitis NO acts indirectly via microcirculatory changes, including inhibition of leucocyte activation and preservation of capillary perfusion.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>9863487</pmid><doi>10.1136/gut.43.3.401</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 1998-09, Vol.43 (3), p.401-407
issn 0017-5749
1468-3288
1458-3288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1727253
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Acute Disease
acute pancreatitis
Animals
Arginine - therapeutic use
Biological and medical sciences
Blood
Cells, Cultured
Ceruletide
Endothelium
Enzyme Inhibitors - pharmacology
Experiments
Gastroenterology. Liver. Pancreas. Abdomen
Laboratory animals
leucocytes
Leukocytes
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
microcirculation
NG-Nitroarginine Methyl Ester - pharmacology
Nitric oxide
Nitric Oxide - physiology
Nitric Oxide Donors - therapeutic use
Nitric Oxide Synthase - antagonists & inhibitors
Nitroprusside - therapeutic use
Oligopeptides - metabolism
Other diseases. Semiology
Pancreas
Pancreas - drug effects
Pancreas - metabolism
Pancreas - pathology
pancreatic secretion
Pancreatitis - metabolism
Pancreatitis - pathology
Pancreatitis - prevention & control
Pathogenesis
Rats
Rats, Sprague-Dawley
Rats, Wistar
Rodents
Spectrum analysis
Vasodilator Agents - therapeutic use
title On the protective mechanisms of nitric oxide in acute pancreatitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A43%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=On%20the%20protective%20mechanisms%20of%20nitric%20oxide%20in%20acute%20pancreatitis&rft.jtitle=Gut&rft.au=Werner,%20J&rft.date=1998-09-01&rft.volume=43&rft.issue=3&rft.spage=401&rft.epage=407&rft.pages=401-407&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.43.3.401&rft_dat=%3Cproquest_pubme%3E4017425991%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779961064&rft_id=info:pmid/9863487&rfr_iscdi=true